# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001140361-25-022574
Filing Date
2025-06-16
Accepted
2025-06-16 12:01:06
Documents
39
Period of Report
2025-06-16
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | ef20050576_8k.htm iXBRL | 8-K | 31801
2 | EXHIBIT 99.1 | ef20050576_ex99-1.htm | EX-99.1 | 47841
6 |  | ef20050576_ex99-1slide1.jpg | GRAPHIC | 131674
7 |  | ef20050576_ex99-1slide2.jpg | GRAPHIC | 95551
8 |  | ef20050576_ex99-1slide3.jpg | GRAPHIC | 71168
9 |  | ef20050576_ex99-1slide4.jpg | GRAPHIC | 87684
10 |  | ef20050576_ex99-1slide5.jpg | GRAPHIC | 157959
11 |  | ef20050576_ex99-1slide6.jpg | GRAPHIC | 156942
12 |  | ef20050576_ex99-1slide7.jpg | GRAPHIC | 72130
13 |  | ef20050576_ex99-1slide8.jpg | GRAPHIC | 196888
14 |  | ef20050576_ex99-1slide9.jpg | GRAPHIC | 142298
15 |  | ef20050576_ex99-1slide10.jpg | GRAPHIC | 196285
16 |  | ef20050576_ex99-1slide11.jpg | GRAPHIC | 152073
17 |  | ef20050576_ex99-1slide12.jpg | GRAPHIC | 118659
18 |  | ef20050576_ex99-1slide13.jpg | GRAPHIC | 84656
19 |  | ef20050576_ex99-1slide14.jpg | GRAPHIC | 111478
20 |  | ef20050576_ex99-1slide15.jpg | GRAPHIC | 138482
21 |  | ef20050576_ex99-1slide16.jpg | GRAPHIC | 144554
22 |  | ef20050576_ex99-1slide17.jpg | GRAPHIC | 137579
23 |  | ef20050576_ex99-1slide18.jpg | GRAPHIC | 137641
24 |  | ef20050576_ex99-1slide19.jpg | GRAPHIC | 110045
25 |  | ef20050576_ex99-1slide20.jpg | GRAPHIC | 106889
26 |  | ef20050576_ex99-1slide21.jpg | GRAPHIC | 84427
27 |  | ef20050576_ex99-1slide22.jpg | GRAPHIC | 129277
28 |  | ef20050576_ex99-1slide23.jpg | GRAPHIC | 93299
29 |  | ef20050576_ex99-1slide24.jpg | GRAPHIC | 130232
30 |  | ef20050576_ex99-1slide25.jpg | GRAPHIC | 105437
31 |  | ef20050576_ex99-1slide26.jpg | GRAPHIC | 111402
| Complete submission text file | 0001140361-25-022574.txt |  | 4636787

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA | galt-20250616.xsd | EX-101.SCH | 3901
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | galt-20250616_lab.xml | EX-101.LAB | 21966
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | galt-20250616_pre.xml | EX-101.PRE | 16068
42 | EXTRACTED XBRL INSTANCE DOCUMENT | ef20050576_8k_htm.xml | XML | 4244

Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31791 | Film No.: 251049076
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)